Securing a reliable vendor for medicinal intermediates in large volume quantities is a critical element of efficient and cost-effective therapeutic manufacturing. Many companies prefer to outsource this aspect of their operations to dedicated providers who maintain the essential infrastructure, skill and regulatory standards. The consistent availab